Trillium Group

Omni-ID Ltd. specializes in developing passive ultra high frequency radio frequency identification (RFID) technology products that are designed for efficient asset tracking and management. The company offers a range of RFID tags, including the Max and Flex tags for various applications such as conveyance, industrial devices, and retail shelving. Additionally, Omni-ID provides the Prox tag for IT asset identification and the ProVIEW system, which combines visual instructions with RFID tracking and process communication software. Their products are engineered to perform reliably in challenging environments, including those involving metals and liquids, ensuring accurate identification of high-value assets. Founded in 2007 and based in Farnham, United Kingdom, Omni-ID serves diverse sectors including information technology, telecommunications, industrial, and retail markets, focusing on cost-effective solutions for tagging, tracking, and monitoring applications.

Omni-ID Ltd. specializes in developing passive ultra high frequency radio frequency identification (RFID) technology products that are designed for efficient asset tracking and management. The company offers a range of RFID tags, including the Max and Flex tags for various applications such as conveyance, industrial devices, and retail shelving. Additionally, Omni-ID provides the Prox tag for IT asset identification and the ProVIEW system, which combines visual instructions with RFID tracking and process communication software. Their products are engineered to perform reliably in challenging environments, including those involving metals and liquids, ensuring accurate identification of high-value assets. Founded in 2007 and based in Farnham, United Kingdom, Omni-ID serves diverse sectors including information technology, telecommunications, industrial, and retail markets, focusing on cost-effective solutions for tagging, tracking, and monitoring applications.

OyaGen, Inc., a biotechnology company, engages in discovering, developing, and commercializing novel pharmaceutical therapies that seek to exploit RNA editing and DNA editing enzymes. Its platform technology encompasses on study of editing enzymes to affect various functions, including antiviral, cancer, immunoglobulin gene rearrangements, inflammation, ion channel function, LDL reduction, neuro-cognitive functions, and red blood cell expression in fetal liver. OyaGen, Inc. was founded in 2003 and is based in Rochester, New York.

ClearMomentum, Inc. provides financial reporting software to venture capital and private equity investors, boards, and limited partners. It offers ClearFinancials, a portfolio monitoring application that collects, validates, and synthesizes private company financial statements; and a Web portal to share investment documents and create custom workflows to increase collaboration. The company also provides an iPad application that enables users to monitor income statements, balance sheets, charts, and commentary sections; access historic commentary with the ability to add, edit, and instantly share updates with other users; and personalize the dashboard and view the data. It provides solutions in the areas of data collection, portfolio monitoring, and reporting. The company was founded in 2005 and is based in Canandaigua, New York. As of January 20, 2015, ClearMomentum, Inc. operates as a subsidiary of Ipreo Holdings LLC.

iCardiac Technologies, Inc. specializes in cardiac safety biomarkers, focusing on the assessment of drug safety profiles through its Dynamic QTbtbsm suite of ECG-based markers. Founded in 2006 and headquartered in Rochester, New York, the company offers a comprehensive range of services that include scientific and medical consultation, study design, data management, ECG analysis, statistical reporting, and regulatory interface. iCardiac's advanced methodologies aim to enhance the precision and accuracy of cardiac safety evaluations in clinical trials, supporting pharmaceutical, biotechnology, and medical device companies in their drug development processes. By providing these specialized services, iCardiac helps ensure that subjects are appropriately included in studies, thereby facilitating more efficient drug development programs.

Communication Synergy Technologies Inc., a Rochester, N.Y.–based developer of document management solutions.

Appairent Technologies, Inc. is a wireless multimedia systems and solutions company that provides radio modules, software and intellectual property to major consumer-electronics manufacturers. Their products - based on industry standards - employ cutting-edge technology to deliver low-power and low-cost streaming multimedia applications, from digital cameras and personal data assistants, to televisions, set-top boxes, MP3 players, laptop computers, digital camcorders and more. Appairent Technologies was formed - and is operated - by experienced consumer-electronics experts, including leaders of the IEEE 802.15 working group and an original co-founder of the 802.11 working group. They're proud to be a member of the IEEE-standards activities and a founding member of the WiMedia Alliance. Appairent Technologies spun off as an independent company from Eastman Kodak Company in January 2002.

VirtualScopics, Inc. provides imaging solutions for clinical trials serving the pharmaceutical, biotechnology, and medical device industries. The company offers a suite of image analysis software tools and applications, which are used in detecting and measuring specific anatomical structures and metabolic activity using medical images. Its image-based measurement and visualization tools enable automated, accurate, and reproducible measurement of changes that occur in anatomic structures in musculoskeletal, oncological, cardiological, and neurological diseases. VirtualScopics has strategic relationship with Pfizer Inc. for the discovery, validation, and application of image-based biomarkers for clinical research. The company was founded in 2000 and is headquartered in Rochester, New York.